Form 8-K - Current report:
SEC Accession No. 0000200406-25-000003
Filing Date
2025-01-22
Accepted
2025-01-22 06:35:57
Documents
18
Period of Report
2025-01-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20250122.htm   iXBRL 8-K 36353
2 EX-99.1 a2024q4exhibit991.htm EX-99.1 149651
3 EX-99.2 a2024q4exhibit992.htm EX-99.2 1247367
8 image_1.jpg GRAPHIC 339
9 jnjlogoa.jpg GRAPHIC 2962
  Complete submission text file 0000200406-25-000003.txt   1698792

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20250122.xsd EX-101.SCH 3478
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20250122_def.xml EX-101.DEF 8162
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20250122_lab.xml EX-101.LAB 32216
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20250122_pre.xml EX-101.PRE 19527
20 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20250122_htm.xml XML 6984
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 25543856
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)